Otto F - Search Results

1

Therapeutic Plasma Exchange in Multiple Sclerosis and Autoimmune Encephalitis: a Comparative Study of Indication, Efficacy and Safety.

Moser T, Harutyunyan G, Karamyan A, Otto F, Bacher C, Chroust V, Leitinger M, Novak HF, Trinka E, Sellner J. Moser T, et al. Among authors: otto f. Brain Sci. 2019 Oct 9;9(10):267. doi: 10.3390/brainsci9100267. Brain Sci. 2019. PMID: 31601005 Free PMC article.

2

Susac's syndrome: clinical course and epidemiology in a Central European population.

Seifert-Held T, Langner-Wegscheider BJ, Komposch M, Simschitz P, Franta C, Teuchner B, Offenbacher H, Otto F, Sellner J, Rauschka H, Fazekas F. Seifert-Held T, et al. Among authors: otto f. Int J Neurosci. 2017 Sep;127(9):776-780. doi: 10.1080/00207454.2016.1254631. Epub 2016 Nov 11. Int J Neurosci. 2017. PMID: 27788613

3

Intravenous thrombolysis in acute ischemic stroke after dabigatran reversal with idarucizumab - a case report.

Mutzenbach JS, Pikija S, Otto F, Halwachs U, Weymayr F, Sellner J. Mutzenbach JS, et al. Among authors: otto f. Ann Clin Transl Neurol. 2016 Sep 17;3(11):889-892. doi: 10.1002/acn3.346. eCollection 2016 Nov. Ann Clin Transl Neurol. 2016. PMID: 27844035 Free PMC article.

4

Causes of death in critically ill multiple sclerosis patients.

Karamyan A, Brandtner H, Grinzinger S, Chroust V, Bacher C, Otto F, Reisp M, Hauer L, Sellner J. Karamyan A, et al. Among authors: otto f. Acta Neurol Scand. 2017 Oct;136(4):305-309. doi: 10.1111/ane.12724. Epub 2016 Dec 23. Acta Neurol Scand. 2017. PMID: 28008594

5

Cerebrospinal fluid CXLC13 indicates disease course in neuroinfection: an observational study.

Pilz G, Wipfler P, Otto F, Hitzl W, Afazel S, Haschke-Becher E, Trinka E, Harrer A. Pilz G, et al. Among authors: otto f. J Neuroinflammation. 2019 Jan 19;16(1):13. doi: 10.1186/s12974-019-1405-8. J Neuroinflammation. 2019. PMID: 30660201 Free PMC article.

6

Beyond LNB: Real life data on occurrence and extent of CSF CXCL13 in neuroinflammatory diseases.

Pilz G, Steger R, Wipfler P, Otto F, Afazel S, Haschke-Becher E, Trinka E, Harrer A. Pilz G, et al. Among authors: otto f. J Neuroimmunol. 2020 Jan 15;338:577087. doi: 10.1016/j.jneuroim.2019.577087. Epub 2019 Nov 2. J Neuroimmunol. 2020. PMID: 31715459

7

Neurological complications associated with influenza in season 2017/18 in Austria- a retrospective single center study.

Mylonaki E, Harrer A, Pilz G, Stalzer P, Otto F, Trinka E, Wipfler P. Mylonaki E, et al. Among authors: otto f. J Clin Virol. 2020 Jun;127:104340. doi: 10.1016/j.jcv.2020.104340. Epub 2020 Mar 30. J Clin Virol. 2020. PMID: 32302952

8

Successful disease control with alemtuzumab in MOG-IgG-associated demyelinating disease with MS-phenotype.

Otto F, Moser T, Feige J, Seiberl M, Bieler L, Sellner J. Otto F, et al. Mult Scler Relat Disord. 2020 Jul;42:102108. doi: 10.1016/j.msard.2020.102108. Epub 2020 Apr 15. Mult Scler Relat Disord. 2020. PMID: 32339987

9

Non-convulsive status epilepticus with right arm apraxia: A case report.

Ladisich B, Otto F, Machegger L, Kleindienst W, Trinka E, Kuchukhidze G. Ladisich B, et al. Among authors: otto f. Epilepsy Behav Rep. 2020 Jun 2;14:100371. doi: 10.1016/j.ebr.2020.100371. eCollection 2020. Epilepsy Behav Rep. 2020. PMID: 32577612 Free PMC article.

10

The CXCL13/CXCR5-chemokine axis in neuroinflammation: evidence of CXCR5+CD4 T cell recruitment to CSF.

Harrer C, Otto F, Pilz G, Haschke-Becher E, Trinka E, Hitzl W, Wipfler P, Harrer A. Harrer C, et al. Among authors: otto f. Fluids Barriers CNS. 2021 Aug 26;18(1):40. doi: 10.1186/s12987-021-00272-1. Fluids Barriers CNS. 2021. PMID: 34446066 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

275 results

Search Page